Intramolecular hydrophobic interactions are critical mediators of STAT5 dimerization
暂无分享,去创建一个
G. Müller-Newen | D. Fahrenkamp | S. Koschmieder | G. Rossetti | B. Lüscher | N. Chatain | Jinyu Li | H. Schmitz-Van de Leur | Sabrina Ernst | A. Küster | Nicolas Chatain
[1] T. Barbui,et al. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both , 2016, Leukemia.
[2] Randy J. Zauhar,et al. An SH2 domain model of STAT5 in complex with phospho-peptides define “STAT5 Binding Signatures” , 2015, Journal of Computer-Aided Molecular Design.
[3] T. Berg,et al. Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a , 2015, Angewandte Chemie.
[4] Can Alkan,et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells , 2015, Nature Communications.
[5] T. Rausch,et al. The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse , 2014, Haematologica.
[6] R. Moriggl,et al. Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia , 2014, OncoTarget.
[7] David E. Muench,et al. Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein , 2014, ACS medicinal chemistry letters.
[8] K. Elenitoba-Johnson,et al. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. , 2014, Blood.
[9] T. Waldmann,et al. Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas , 2014, Leukemia.
[10] O. Lohi,et al. Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia , 2014, Leukemia.
[11] S. Mustjoki,et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. , 2013, Blood.
[12] W. Vainchenker,et al. JAK/STAT signaling in hematological malignancies , 2013, Oncogene.
[13] Luigi Atzori,et al. Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study , 2013, PloS one.
[14] J. Griffin,et al. The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations. , 2012, Genes & cancer.
[15] L. S. Swapna,et al. Extent of Structural Asymmetry in Homodimeric Proteins: Prevalence and Relevance , 2012, PloS one.
[16] M. Farrar,et al. The role of STAT5 in lymphocyte development and transformation. , 2012, Current opinion in immunology.
[17] Roman A. Laskowski,et al. LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery , 2011, J. Chem. Inf. Model..
[18] Ioannis Xenarios,et al. T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension , 2011, Nucleic Acids Res..
[19] G. Müller-Newen,et al. The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3 , 2009, Journal of Cell Science.
[20] R. Dror,et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.
[21] L. Hennighausen,et al. Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia , 2010, EMBO molecular medicine.
[22] M. Kerenyi,et al. Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V. , 2009, The American journal of pathology.
[23] B. Aggarwal,et al. Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer , 2009, Annals of the New York Academy of Sciences.
[24] L. Kenner,et al. Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade. , 2008, Blood.
[25] L. Hennighausen,et al. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. , 2008, Genes & development.
[26] E. Vellenga,et al. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells. , 2007, Blood.
[27] A. Alonso,et al. Cutting Edge: Selective Tyrosine Dephosphorylation of Interferon-Activated Nuclear STAT5 by the VHR Phosphatase1 , 2007, The Journal of Immunology.
[28] K. D. Bunting,et al. STAT5 signaling in normal and pathologic hematopoiesis. , 2007, Frontiers in bioscience : a journal and virtual library.
[29] G. V. Goersch,et al. cDNA cloning and 1.75 Å crystal structure determination of PPL2, an endochitinase and N‐acetylglucosamine‐binding hemagglutinin from Parkia platycephala seeds , 2006, The FEBS journal.
[30] A. Sali,et al. A composite score for predicting errors in protein structure models , 2006, Protein science : a publication of the Protein Society.
[31] R. Ilaria,et al. STAT5 signaling is required for the efficient induction and maintenance of CML in mice. , 2006, Blood.
[32] L. Hennighausen,et al. Stat5a/b are essential for normal lymphoid development and differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Becker,et al. Structure of the Unphosphorylated STAT5a Dimer* , 2005, Journal of Biological Chemistry.
[34] Glen B. Legge,et al. An AMBER/DYANA/MOLMOL Phosphorylated Amino Acid Library Set and Incorporation into NMR Structure Calculations , 2005, Journal of biomolecular NMR.
[35] Lenwood S. Heath,et al. H++: a server for estimating pKas and adding missing hydrogens to macromolecules , 2005, Nucleic Acids Res..
[36] E. Wagner,et al. Stat5 tetramer formation is associated with leukemogenesis. , 2005, Cancer cell.
[37] O. Silvennoinen,et al. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. , 2004, Cytokine & growth factor reviews.
[38] R. Marmorstein,et al. Structure and substrate binding properties of cobB, a Sir2 homolog protein deacetylase from Escherichia coli. , 2004, Journal of molecular biology.
[39] David R. Klug,et al. Large and Fast Relaxations inside a Protein: Calculation and Measurement of Reorganization Energies in Alcohol Dehydrogenase , 2002 .
[40] B. Hess. Convergence of sampling in protein simulations. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.
[41] 有好 浩一. Constitutive activation of STAT5 by a point mutation in the SH2 domain , 2002 .
[42] T Pawson,et al. SH2 domains, interaction modules and cellular wiring. , 2001, Trends in cell biology.
[43] A. Sali,et al. Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.
[44] A J Olson,et al. Structural symmetry and protein function. , 2000, Annual review of biophysics and biomolecular structure.
[45] A. Miyajima,et al. Constitutive Activation of STAT5 by a Point Mutation in the SH2 Domain* , 2000, The Journal of Biological Chemistry.
[46] S. Becker,et al. Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.
[47] R. Cherry,et al. Mobility of cell surface receptors: a re‐evaluation , 1998, FEBS letters.
[48] G. McGaughey,et al. pi-Stacking interactions. Alive and well in proteins. , 1998, The Journal of biological chemistry.
[49] J. Darnell,et al. Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA , 1998, Cell.
[50] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..
[51] Alexander D. MacKerell,et al. A molecular mechanics force field for NAD+ NADH, and the pyrophosphate groups of nucleotides , 1997, J. Comput. Chem..
[52] D. van der Spoel,et al. GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .
[53] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[54] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[55] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[56] J. Åqvist,et al. Ion-water interaction potentials derived from free energy perturbation simulations , 1990 .
[57] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[58] G. N. Ramachandran,et al. Stereochemistry of polypeptide chain configurations. , 1963, Journal of molecular biology.